AvePoint to Participate in Upcoming Investor Conferences
11. November 2024 09:00 ET
|
AvePoint, Inc.
JERSEY CITY, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in robust data management and data governance, today announced that members of the Company’s executive...
ITM to Participate in Upcoming Investor Conferences
11. November 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...
Immunocore to present at upcoming investor conferences
08. November 2024 07:00 ET
|
Immunocore Holdings plc
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology...
Surrozen to Present at Upcoming Healthcare Investor Conferences
06. November 2024 16:30 ET
|
Surrozen, Inc.
Surrozen to Present at Upcoming Healthcare Investor Conferences in November 2024
Chemomab Therapeutics to Present at October 2024 Investor Conferences
01. Oktober 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab will participate in the ROTH Healthcare Opportunities Conference in NYC on Oct 9 and the Maxim Healthcare Virtual Summit on Oct 16 at 9am ET.
ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
19. September 2024 05:22 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, September 19, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry...
Katapult to Participate in H.C. Wainwright 26th Annual Global Investment Conference
05. September 2024 07:00 ET
|
Katapult Holdings, Inc.
Katapult to participate in investor conference
GeoVax to Participate in Upcoming Investor Conferences in September
03. September 2024 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
Arbutus to Participate in Two Upcoming Investor Conferences
03. September 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Chemomab Therapeutics to Present at September 2024 Investor Conferences
28. August 2024 07:00 ET
|
Chemomab Therapeutics
Chemomab will be presenting at the HC Wainwright Global Investment Conference and the HBM Biopharma Summit in September